AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹14,794 Cr | ₹14,493 Cr | ₹11,024 Cr | ₹10,532 Cr | ₹9,374 Cr |
What is the latest Net Block ratio of AUROBINDO PHARMA ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹14,794 Cr |
| Mar2024 | ₹14,493 Cr |
| Mar2023 | ₹11,024 Cr |
| Mar2022 | ₹10,532 Cr |
| Mar2021 | ₹9,374 Cr |
How is Net Block of AUROBINDO PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,794 Cr | 2.08 | |
| Mar2024 | ₹14,493 Cr | 31.47 | |
| Mar2023 | ₹11,024 Cr | 4.67 | |
| Mar2022 | ₹10,532 Cr | 12.36 | |
| Mar2021 | ₹9,374 Cr | - | |
Compare Net Block of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹86,186.3 Cr | 6.5% | -1.3% | 25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 6.5% |
-1.3% |
25.4% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses